Bellevue Group - substantial expansion of asset management activities
with a distinct profile
(Thomson Reuters ONE) - Corporate news announcement processed and transmitted by Hugin AS.The issuer is solely responsible for the content of this announcement. ------------------------------------------------------------------------------------ Bellevue Group has steadfastly implemented the strategic expansion ofits asset management activities announced earlier this year. As aspecialized asset management boutique focused on investing inhealthcare stocks, "new markets" and selected stock-market niches,the company offers a clear and distinct core competency profile. Itsoffering of investment products has recently been broadened with thelaunch of new vehicles that also allow Bellevue Asset Management toaddress new market segments. With CHF 2.6 billion in assets undermanagement and an expert team of 30 highly experienced analysts,portfolio managers and product specialists, Bellevue Group ranksamong the leading cross-border providers of investment vehicles forthe healthcare sector.Steadfast strategic expansionDespite the financial crisis Bellevue Group has largely completed thestrategic expansion of its asset management activities throughanti-cyclical investment in personnel and infrastructure. Expansionhas been focused on actively managed equity investment vehicles forselected sectors and regions, based on a fundamental andresearch-driven stock-picking approach. Sectors such as thehealthcare, or emerging markets that are still displaying high marketinefficiencies, are particularly suited for active investmentstrategies. In these cases active portfolio management can producetangible value added provided the requisite skills are available.This has led to a trend toward increasing specialization in the assetmanagement industry. Our positioning is based on our long-standingand strong research skills in the healthcare industry and in Swissequities, two areas where we occupy a prominent position as a leadinginternational player. We have enhanced our expertise in new marketsand in attractive growth niches for Swiss and international equityinvestments, where we are likewise focusing on long-term andstructurally driven investment trends," explains André Rüegg, Head ofSales and Marketing at Bellevue Asset Management. "As a boutique witha disciplined strategic focus, this has been our guiding principlefor more than 16 years."Quantitative und qualitative expansion of portfolio managementactivitiesAdditional specialists were recruited to build upon our long-standingand interdisciplinary healthcare competencies with approximately CHF2.6 billion in assets under management. An experienced team was alsohired for the newly created "New Markets" investment theme. Ourportfolio management staff was thus increased by half to a total of24 investment specialists. This successful recruitment campaign, likeour previous success in hiring experienced client advisors andmarketing and product specialists, demonstrates Bellevue Group'sappeal to talented investment professionals on the national andinternational stage. Substantial investments in corporateinfrastructure and modern risk management processes were also madeduring the period of expansion in the first half of the year.Successful launch of new productsA venture capital product, a hedge fund and five specialized UCITSIII Luxembourg-based equity funds have been added to our range ofservices and products. The latter are based on the new Bellevue Funds(Lux) Sicav and have been registered for distribution in Switzerland,Germany, Austria and Luxembourg. This new platform will allowBellevue Group to expand its customer base across the Europeancontinent. Its offering of new equity funds ranges from itslong-standing group-wide investment competency (BB Selection), to NewMarkets products such asBB Silk Road Opportunities and BB African Opportunities, to Europeanniche strategies(BB Entrepreneur Europe). An equity fund under Luxembourg law waslaunched on March 31, 2009 to supplement the investment company BBBiotech, the group's flagship product with a market capitalization ofCHF 1.5 billion. The range of Luxembourg products will include theequity fund BB Medtech (Lux) by the end of September provided theshareholders accept the proposed transformation of the listedinvestment company BB Medtech AG. The subscription period for BBBiotech Ventures III was resoundingly successful, having attractedsome USD 100 million from institutional and private investors.The new products have got off to a good start in terms of performanceand investor acceptance. Bellevue Asset Management now offers acomprehensive, complementary range of products consisting of:* Investment funds for institutional and private clients;* Investment companies;* Selected alternative investments in the form of hedge funds and private equity/venture vehicles;* Specialized institutional mandates.Platform for future growth in placeBellevue Group has used the financial crisis to significantlystrengthen its position. It now has outstanding growth prospects,partly contingent on the stabilization of financial markets andrestored investor trust in stock markets.Please direct your enquiries to:Media: Andre Rüegg (aru(at)bellevue.ch), Anja Stubenrauch(as(at)bellevue.ch)Telephone +41 44 267 67 00, Fax +41 44 267 77 02The Bellevue Group is an independent Swiss financial group domiciledin Küsnacht. The company is listed on the Swiss stock exchanges.Bank am Bellevue is a provider of research and brokerage services inSwiss equities and selected international stocks as well as corporatefinance services.Bellevue Asset Management manages specialized equity investmentvehicles focused on selected sector and regional strategies andprovides selected institutional asset management services.Newly recruited Portfolio Managers / Analysts at Bellevue AssetManagement+-------------------------------------------------------------------+| Last name | First name | Function | Focus | Job || | | | | experience ||-----------+------------+---------------+-------------+------------|| Bernhardt | Eric | Head | Healthcare | 24 years || | | Portfolio | | || | | Manager | | ||-----------+------------+---------------+-------------+------------|| Reeder | Kevin | Senior | Healthcare | 7 years || | | Portfolio | | || | | Manager | | ||-----------+------------+---------------+-------------+------------|| Fox | Matthew | Senior | Healthcare | 6 years || | | Portfolio | | || | | Manager | | ||-----------+------------+---------------+-------------+------------|| Hofmann | Corinne | Portfolio | Healthcare | 5 years || | | Manager | | ||-----------+------------+---------------+-------------+------------|| Zuzak | Miroslav | Portfolio | European | 3 years || | | Manager | Equities | || | | | | ||-----------+------------+---------------+-------------+------------|| Shalash | Alexander | Head | New Markets | 16 years || | | Portfolio | | || | | Manager | | || | | | | ||-----------+------------+---------------+-------------+------------|| Bou-Diab | Malek | Senior | New Markets | 6 years || | | Portfolio | | || | | Manager | | || | | | | ||-----------+------------+---------------+-------------+------------|| Ogram | Elena | Senior | New Markets | 6 years || | | Portfolio | | || | | Manager | | || | | | | |+-------------------------------------------------------------------+New equity-based fund products at Bellevue Asset Management+---------------------------------------------------------------------------+|Equity fund |No. of |Fees |Legal form|Investment|Currency || |stocks | | |style | || | | | | | ||---------------+--------+-----------------+----------+----------+----------||BB Biotech |30 to 40|1.60% p.a. |Luxemburg |Bottom-up |USD; (CHF,||(Lux) | |B-Shares |SICAV |stock |EUR || | |0.90% p.a. |Fonds, |picking |unhedged) || | |I-Shares |Partie I | | || | | | | | ||---------------+--------+-----------------+----------+----------+----------||BB Medtech |30 to 40|1.60% p.a. |Luxemburg |Bottom-up |EUR (CHF, ||(Lux) | |B-Shares |SICAV |stock |unhedged) || | |0.90% p.a. |Fonds, |picking | || | |I-Shares |Partie I | | ||---------------+--------+-----------------+----------+----------+----------||BB Healthcare |30 to 50|1.60% p.a. |Luxemburg |Bottom-up |USD; (CHF,||(Lux)* | |B-Shares |SICAV |stock |EUR || | |0.90% p.a. |Fonds, |picking |unhedged) || | |I-Shares |Partie I | | || | | | | | ||---------------+--------+-----------------+----------+----------+----------||BB Selection |30 to 50|1.40% p.a. |Luxemburg |Bottom-up |EUR (CHF, ||(Lux) | |B-Shares |SICAV |stock |unhedged) || | |0.80% p.a. |Fonds, |picking | || | |I-Shares |Partie I | | || | |+15% Performance | | | || | |Fee above 3M EUR | | | || | |Libor + 4% p.a. | | | || | | | | | ||---------------+--------+-----------------+----------+----------+----------||BB Entrepreneur|30 to 50|1.60% p.a. |Luxemburg |Bottom-up |EUR (CHF, ||Europe (Lux) | |B-Shares |SICAV |stock |unhedged) || | |0.90% p.a. |Fonds, |picking | || | |I-Shares |Partie I | | || | | | | | ||---------------+--------+-----------------+----------+----------+----------||BB African |50 to 70|1.60% p.a. |Luxemburg |Bottom-up |EUR (CHF, ||Opportunities | |B-Shares |SICAV |stock |USD, ||(Lux) | |0.90% p.a. |Fonds, |picking |unhedged) || | |I-Shares |Partie I | | || | | | | | ||---------------+--------+-----------------+----------+----------+----------||BB Silk Road |50 to 70|1.60% p.a. |Luxemburg |Bottom-up |EUR (CHF, ||Opportunities | |B-Shares |SICAV |stock |USD, ||(Lux) | |0.90% p.a. |Fonds, |picking |unhedged) || | |I-Shares |Partie I | | || | | | | | |+---------------------------------------------------------------------------+*Launch scheduled for September 30, 2009http://hugin.info/137269/R/1337763/318898.pdf --- End of Message ---Bellevue Group AGSeestrasse 16, Postfach Küsnacht/Zürich SwitzerlandWKN: A0LG3Z; ISIN: CH0028422100; Index: SPI, SPIEX, SSCI;;
Datum: 27.08.2009 - 18:32 Uhr
Sprache: Deutsch
News-ID 5200
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 2353 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Bellevue Group - substantial expansion of asset management activities
with a distinct profile"
steht unter der journalistisch-redaktionellen Verantwortung von
Bellevue Group AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
